Working... Menu

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918) (SMARTMSP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03257436
Recruitment Status : Recruiting
First Posted : August 22, 2017
Last Update Posted : June 3, 2019
ICON Clinical Research
Information provided by (Responsible Party):
Boston Scientific Corporation

Brief Summary:
Prospective, multi-center, single arm, post approval study to be conducted in the United States.

Condition or disease Intervention/treatment Phase
Left Ventricular Dysfunction Device: CRT-D Not Applicable

Detailed Description:
Evaluate the effectiveness of Boston Scientific (BSC)'s LV MSP (Left Ventricular MultiSite Pacing) feature in the Resonate family of CRT-D devices1 and confirm safety in a post approval study when used in accordance with its approved labeling.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 586 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
Actual Study Start Date : December 13, 2017
Estimated Primary Completion Date : April 2020
Estimated Study Completion Date : July 2020

Arm Intervention/treatment
Single Arm
General population who receive a Boston Scientific Resonate family of CRT-D device in accordance with its labeled indication for use.
Device: CRT-D
Left Ventricular MultiSite Pacing

Primary Outcome Measures :
  1. LV MSP feature [ Time Frame: Between 6 month visit and the 12 month visit in non-responders with LV MSP on for any duration. ]
    Related complication-free rate.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. Subjects who received de novo implantation of BSC's Resonate family of CRT-D devices with the LV MSP feature4 and BSC's ACUITYTM X4 LV Quadripolar leads. A Resonate family of CRT-D device upgrade from previous single or dual chamber pacemaker or ICD implantation is allowed.
  2. Subjects must meet BSC labeled indication for CRT-D implantation.
  3. Subjects must have a functional RA lead and RV lead implanted
  4. Subjects who are willing and capable of providing informed consent
  5. Subjects who are willing and capable of participating in all testing/visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol
  6. Subjects who are age 18 and above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

  1. Subjects who received LV pacing prior to receiving the Resonate family of CRT-D system implantation.
  2. Subjects who received the LV MSP therapy post CRT-D implantation but prior to enrollment
  3. Subjects with documented history of permanent AF
  4. Subjects with documented permanent complete AV block
  5. Subjects who are expected to receive a heart transplant during the 12 months course of the study
  6. Subjects with documented life expectancy of less than 12 months
  7. Subjects who enrolled in any other concurrent study or registry, with the exception of mandatory national or governmental registry, without prior written approval from BSC

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03257436

  Show 57 Study Locations
Sponsors and Collaborators
Boston Scientific Corporation
ICON Clinical Research

Layout table for additonal information
Responsible Party: Boston Scientific Corporation Identifier: NCT03257436     History of Changes
Other Study ID Numbers: 92050975
First Posted: August 22, 2017    Key Record Dates
Last Update Posted: June 3, 2019
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: Yes

Keywords provided by Boston Scientific Corporation:

Additional relevant MeSH terms:
Layout table for MeSH terms
Ventricular Dysfunction
Ventricular Dysfunction, Left
Heart Diseases
Cardiovascular Diseases